{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:16:31Z","timestamp":1792818991550,"version":"4.5.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.atherosclerosis.2014.12.042","type":"journal-article","created":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T05:05:55Z","timestamp":1419397555000},"page":"73-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Bilirubin, platelet activation and heart disease: A missing link to cardiovascular protection in Gilbert's syndrome?"],"prefix":"10.1016","volume":"239","author":[{"given":"Avinash R.","family":"Kundur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Bulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.042_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbalip.2006.03.014","article-title":"Oxidative stress and arachidonic acid mobilization","volume":"1761","author":"Balboa","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2014.12.042_bib2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1186\/1471-2458-10-627","article-title":"Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina","volume":"10","author":"Rubinstein","year":"2010","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.042_bib3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/CIRCULATIONAHA.111.040170","article-title":"Reducing the global burden of ischemic heart disease and stroke: a challenge for the cardiovascular community and the United Nations","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"issue":"9765","key":"10.1016\/j.atherosclerosis.2014.12.042_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(10)62346-X","article-title":"Stemming the global tsunami of cardiovascular disease","volume":"377","author":"Anand","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.042_bib5","first-page":"421","article-title":"Oxidative stress in cardiovascular disease","volume":"46","author":"Lakshmi","year":"2009","journal-title":"Indian J. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.042_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF02898101","article-title":"Antioxidants and cardiovascular disease: still a topic of interest","volume":"9","author":"Nojiri","year":"2004","journal-title":"Environ. Health Prev. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.042_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1067\/mnc.2001.114150","article-title":"Oxidative stress in cardiovascular disease","volume":"8","author":"Parthasarathy","year":"2001","journal-title":"J.\u00a0Nucl. Cardiol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.042_bib8","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.freeradbiomed.2011.05.004","article-title":"Reactive oxygen species in cardiovascular disease","volume":"51","author":"Sugamura","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"24","key":"10.1016\/j.atherosclerosis.2014.12.042_bib9","doi-asserted-by":"crossref","first-page":"16712","DOI":"10.1016\/S0021-9258(19)89449-8","article-title":"Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation","volume":"269","author":"Neuzil","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2014.12.042_bib10","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1073\/pnas.84.16.5918","article-title":"Antioxidant activity of albumin-bound bilirubin","volume":"84","author":"Stocker","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.042_bib11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0006-2952(95)02395-X","article-title":"Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins","volume":"51","author":"Wu","year":"1996","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib12","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2007.11.022","article-title":"Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection","volume":"199","author":"Bulmer","year":"2008","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/09537104.2013.764405","article-title":"Unconjugated bilirubin inhibits collagen induced platelet activation","volume":"25","author":"Kundur","year":"2014","journal-title":"Platelets"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.12.042_bib14","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.biocel.2013.09.014","article-title":"The molecular basis for the immunomodulatory activities of unconjugated bilirubin","volume":"45","author":"Jangi","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2014.12.042_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM200102223440807","article-title":"Drug therapy: neonatal hyperbilirubinemia","volume":"344","author":"Dennery","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.042_bib16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/15353702-0322805-29","article-title":"Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies","volume":"228","author":"Novotn\u00fd","year":"2003","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.042_bib17","first-page":"47","article-title":"Chapter 3-Serum bilirubin levels and cardiovascular disease risk: a Janus Bifrons?","volume":"vol. 50","author":"Franchini","year":"2010"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2008.01.001","article-title":"Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin","volume":"198","author":"Schwertner","year":"2008","journal-title":"Atherosclerosis"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2014.12.042_bib19","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.jacc.2012.08.979","article-title":"Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events","volume":"60","author":"Tsimikas","year":"2012","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2014.12.042_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mrrev.2007.05.001","article-title":"The anti-mutagenic properties of bile pigments","volume":"658","author":"Bulmer","year":"2008","journal-title":"Mutat. Res."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.042_bib21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1586\/eem.10.65","article-title":"Bilirubin, cardiovascular diseases and cancer: epidemiological perspectives","volume":"5","author":"Ohnaka","year":"2010","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2014.12.042_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/jech-2012-201753.126","article-title":"Serum bilirubin and risk of cardiovascular events and death in a statin-treated population: a cohort study","volume":"66","author":"Horsfall","year":"2012","journal-title":"J.\u00a0Epidemiol. Community Health"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2014.12.042_bib23","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/jgh.12279","article-title":"Gilbert's syndrome and the risk of death: a population-based cohort study","volume":"28","author":"Horsfall","year":"2013","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajmg.10209","article-title":"Frequencies of UDP-glucuronosyltransferase 1 (UGT1A1) gene promoter polymorphisms among distinct ethnic groups from Brazil","volume":"108","author":"Fertrin","year":"2002","journal-title":"Am. J. Med. Genet."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000133513","article-title":"Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37","volume":"63","author":"Van Es","year":"1993","journal-title":"Cytogenet. Genome Res."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.042_bib26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/14622416.9.6.703","article-title":"Pharmacogenetics of Gilbert's syndrome","volume":"9","author":"Strassburg","year":"2008","journal-title":"Pharmacogenomics"},{"issue":"9524","key":"10.1016\/j.atherosclerosis.2014.12.042_bib27","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(06)68770-9","article-title":"Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data","volume":"367","author":"Lopez","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1523-1755.1999.00302.x","article-title":"Alterations in nonenzymatic biochemistry in uremia: origin and significance of \u201ccarbonyl stress\u201d in long-term uremic complications","volume":"55","author":"Miyata","year":"1999","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2014.12.042_bib29","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2337\/diacare.23.8.1182","article-title":"Oxidative stress in families of type 1 diabetic patients","volume":"23","author":"Matteucci","year":"2000","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jhn.12177","article-title":"A\u00a0review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic risk","volume":"27","author":"Santhakumar","year":"2014","journal-title":"J.\u00a0Hum. Nutr. Diet"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.numecd.2006.09.001","article-title":"The effects of polyphenols in olive leaves on platelet function","volume":"18","author":"Singh","year":"2008","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"key":"10.1016\/j.atherosclerosis.2014.12.042_bib32","first-page":"147","article-title":"The synergistic effect of taurine and caffeine on platelet activity and hemostatic function","volume":"3","author":"Santhakumar","year":"2013","journal-title":"Food Public Health"},{"key":"10.1016\/j.atherosclerosis.2014.12.042_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5923\/j.fph.20120202.10","article-title":"Taurine in lower concentration attenuates platelet activity","volume":"2","author":"Santhakumar","year":"2012","journal-title":"Food Public Health"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.12.042_bib34","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.clinbiochem.2009.02.005","article-title":"Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: a link to protection against atherosclerosis?","volume":"42","author":"Tapan","year":"2009","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.042_bib35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/CS20120661","article-title":"Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome","volume":"125","author":"Wallner","year":"2013","journal-title":"Clin. Sci. (Lond.)"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2014.12.042_bib36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3109\/10641963.2012.758277","article-title":"Investigation of the aortic pulse wave velocity in patients with Gilbert's syndrome","volume":"35","author":"Arslan","year":"2013","journal-title":"Clin. Exp. Hypertens."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0021-9150(96)05980-1","article-title":"Hypothesis: is soluble P-selectin a new marker of platelet activation?","volume":"128","author":"Blann","year":"1997","journal-title":"Atherosclerosis"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2014.12.042_bib38","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2010-01-261206","article-title":"Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis","volume":"116","author":"Lievens","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2012.11.001","article-title":"Bilirubin and beyond: a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection","volume":"52","author":"Bulmer","year":"2013","journal-title":"Prog. Lipid Res."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.042_bib40","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.mehy.2006.12.069","article-title":"\u2018Iatrogenic Gilbert syndrome\u2019\u2013a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin","volume":"69","author":"McCarty","year":"2007","journal-title":"Med. Hypotheses"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2014.12.042_bib41","doi-asserted-by":"crossref","first-page":"H1142","DOI":"10.1152\/ajpheart.00001.2014","article-title":"Hyperbilirubinemia modulates myocardial function, aortic ejection and ischemic stress-resistance in the Gunn rat","volume":"307","author":"Bakrania","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1432-1033.1995.467_2.x","article-title":"Changes in the composition of bilirubin-IX isomers during human prenatal development","volume":"233","author":"Yamaguchi","year":"1995","journal-title":"Eur. J. Biochem."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.042_bib43","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1478-3231.2008.01716.x","article-title":"Bilirubin in clinical practice: a review","volume":"28","author":"Fevery","year":"2008","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.042_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.siny.2009.10.005","article-title":"Controversies in bilirubin biochemistry and their clinical relevance","volume":"15","author":"McDonagh","year":"2010","journal-title":"Semin. Fetal Neonatal Med."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1172\/JCI59526","article-title":"Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver","volume":"122","author":"van de Steeg","year":"2012","journal-title":"J.\u00a0Clin. Investig"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib46","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.09.045","article-title":"Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-kappaB leads to hyperbilirubinemia","volume":"142","author":"Fujiwara","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.042_bib47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bpg.2010.07.007","article-title":"Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome)","volume":"24","author":"Strassburg","year":"2010","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.042_bib48","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1067\/mge.2001.117546","article-title":"Expression of bacterial beta-glucuronidase in human bile: an in\u00a0vitro study","volume":"54","author":"Leung","year":"2001","journal-title":"Gastrointest. Endosc."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jchromb.2006.01.032","article-title":"Identification of bilirubin reduction products formed by Clostridium perfringens isolated from human neonatal fecal flora","volume":"833","author":"Vitek","year":"2006","journal-title":"J.\u00a0Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.042_bib50","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/ars.2004.6.841","article-title":"Antioxidant activities of bile pigments","volume":"6","author":"Stocker","year":"2004","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/abbi.1998.0584","article-title":"Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma","volume":"352","author":"Minetti","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"issue":"25","key":"10.1016\/j.atherosclerosis.2014.12.042_bib52","doi-asserted-by":"crossref","first-page":"16093","DOI":"10.1073\/pnas.252626999","article-title":"Biliverdin reductase: a major physiologic cytoprotectant","volume":"99","author":"Bara\u00f1ano","year":"2002","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.042_bib53","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.freeradbiomed.2010.06.001","article-title":"The biliverdin-bilirubin antioxidant cycle of cellular protection: missing a wheel?","volume":"49","author":"McDonagh","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"43","key":"10.1016\/j.atherosclerosis.2014.12.042_bib54","doi-asserted-by":"crossref","first-page":"29251","DOI":"10.1074\/jbc.M109.037119","article-title":"Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase","volume":"284","author":"Maghzal","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.042_bib55","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1542\/peds.113.6.1776","article-title":"Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle","volume":"113","author":"Sedlak","year":"2004","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.12.042_bib56","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1161\/STROKEAHA.109.560649","article-title":"Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women","volume":"40","author":"Kimm","year":"2009","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib57","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.atherosclerosis.2005.05.011","article-title":"Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women","volume":"184","author":"Erdogan","year":"2006","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.hjr.0000230097.81202.9f","article-title":"Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME)","volume":"14","author":"Troughton","year":"2007","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib59","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/01.ATV.16.2.250","article-title":"Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease","volume":"16","author":"Hopkins","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/clinchem\/40.1.18","article-title":"Association of low serum concentration of bilirubin with increased risk of coronary artery disease","volume":"40","author":"Schwertner","year":"1994","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0021-9150(97)06088-7","article-title":"Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults","volume":"131","author":"Madhavan","year":"1997","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MCA.0b013e32835b0c13","article-title":"Inverse relationship between serum total bilirubin levels and severity of disease in patients with stable coronary artery disease","volume":"24","author":"Turfan","year":"2013","journal-title":"Coron. Artery Dis."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.12.042_bib63","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1194\/jlr.P013193","article-title":"Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?","volume":"52","author":"de Sauvage Nolting","year":"2011","journal-title":"J.\u00a0Lipid Res."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2014.12.042_bib64","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/clinchem\/41.10.1504","article-title":"Serum bilirubin and risk of ischemic heart disease in middle-aged British men","volume":"41","author":"Breimer","year":"1995","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib65","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.atherosclerosis.2009.02.010","article-title":"Low serum bilirubin concentration is associated with coronary artery calcification (CAC)","volume":"206","author":"Tanaka","year":"2009","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.042_bib66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/174182679600300508","article-title":"Serum bilirubin and cardiovascular risk factors in a Chinese population","volume":"3","author":"Ko","year":"1996","journal-title":"J.\u00a0Cardiovasc. Risk"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib67","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.atherosclerosis.2008.07.021","article-title":"Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents","volume":"203","author":"Lin","year":"2009","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib68","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0021-9150(99)00387-1","article-title":"Comparison of various lipid, lipoprotein, and bilirubin combinations as risk factors for predicting coronary artery disease","volume":"150","author":"Schwertner","year":"2000","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.042_bib69","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0021-9150(00)00420-2","article-title":"Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study","volume":"154","author":"Hunt","year":"2001","journal-title":"Atherosclerosis"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2014.12.042_bib70","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.106.633206","article-title":"Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study","volume":"114","author":"Lin","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib71","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0021-9150(01)00601-3","article-title":"Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels","volume":"160","author":"V\u0131\u0301tek","year":"2002","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib72","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/ATVBAHA.107.153262","article-title":"Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease","volume":"28","author":"Perlstein","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.12.042_bib73","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/jama.298.12.1398-b","article-title":"Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes","volume":"298","author":"Inoguchi","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2014.12.042_bib74","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fphar.2012.00055","article-title":"The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases","volume":"3","author":"Vitek","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"19\u201320","key":"10.1016\/j.atherosclerosis.2014.12.042_bib75","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.cca.2010.06.003","article-title":"Inverse relationship between fasting direct bilirubin and metabolic syndrome in Korean adults","volume":"411","author":"Hwang","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.numecd.2011.03.001","article-title":"Relationships between serum total bilirubin levels and metabolic syndrome in Korean adults","volume":"23","author":"Choi","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.042_bib77","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1210\/en.2013-1667","article-title":"Bilirubin increases insulin sensitivity in leptin-receptor deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation","volume":"155","author":"Dong","year":"2014","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib78","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1152\/ajprenal.00039.2014","article-title":"Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations","volume":"307","author":"Boon","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2014.12.042_bib79","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1440-1746.2008.05388.x","article-title":"Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome","volume":"23","author":"Yesilova","year":"2008","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.042_bib80","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/CIRCULATIONAHA.112.105775","article-title":"Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome","volume":"126","author":"Maruhashi","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.042_bib81","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcm.2013.12.001","article-title":"Oxidative stress and endothelial dysfunction: clinical evidence and therapeutic implications","volume":"24","author":"Higashi","year":"2014","journal-title":"Trends Cardiovasc. Med."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2014.12.042_bib82","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1158\/1940-6207.CAPR-13-0125","article-title":"Anti-genotoxic potential of bilirubin in\u00a0vivo: damage to DNA in hyperbilirubinemic human and animal models","volume":"6","author":"Wallner","year":"2013","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.atherosclerosis.2014.12.042_bib83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fphar.2012.00039","article-title":"Bile pigments in pulmonary and vascular disease","volume":"3","author":"Ryter","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2014.12.042_bib84","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.freeradbiomed.2012.03.002","article-title":"Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome","volume":"52","author":"Boon","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.042_bib85","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clinbiochem.2010.12.003","article-title":"Decreased small dense LDL levels in Gilbert's syndrome","volume":"44","author":"Tapan","year":"2011","journal-title":"Clin. Biochem."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.042_bib86","first-page":"360","article-title":"Relationship between unconjugated hyperbilirubinemia and lipoprotein spectrum","volume":"32","author":"Ocadlik","year":"2011","journal-title":"Neuro Endocrinol. Lett."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.042_bib87","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1440-1746.2006.04564.x","article-title":"Urinary excretion of oxidative metabolites of bilirubin in subjects with Gilbert syndrome","volume":"22","author":"Vitek","year":"2007","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"issue":"16\u201317","key":"10.1016\/j.atherosclerosis.2014.12.042_bib88","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.clinbiochem.2014.08.008","article-title":"Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus","volume":"47","author":"Dullaart","year":"2014","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.042_bib89","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.diabet.2014.04.006","article-title":"Serum bilirubin as a predictor of incident metabolic syndrome: a 4-year retrospective longitudinal study of 6205 initially healthy Korean men","volume":"40","author":"Lee","year":"2014","journal-title":"Diabetes Metab."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib90","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.ATV.0000148405.18071.6a","article-title":"Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction","volume":"25","author":"Kawamura","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.12.042_bib91","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1161\/01.ATV.0000185806.61430.7c","article-title":"High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions","volume":"25","author":"Gullu","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib92","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.STR.32.2.580-b","article-title":"High serum bilirubin level is inversely associated with the presence of carotid plaque","volume":"32","author":"Ishizaka","year":"2001","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib93","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri2675","article-title":"Macrophage death and defective inflammation resolution in atherosclerosis","volume":"10","author":"Tabas","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2014.12.042_bib94","first-page":"71","article-title":"Interaction between the coagulation and complement system","volume":"632","author":"Amara","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.12.042_bib95","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1515\/cclm.2011.662","article-title":"Relationship between bilirubin and C-reactive protein","volume":"49","author":"Hwang","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.12.042_bib96","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/eci.12120","article-title":"Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome","volume":"43","author":"Wallner","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"issue":"6667","key":"10.1016\/j.atherosclerosis.2014.12.042_bib97","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.042_bib98","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1084\/jem.174.4.785","article-title":"Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production","volume":"174","author":"Hawrylowicz","year":"1991","journal-title":"J.\u00a0Exp. Med."},{"issue":"218","key":"10.1016\/j.atherosclerosis.2014.12.042_bib99","first-page":"1000218","article-title":"Endogenous tetrapyrroles influence leukocyte responses to lipopolysaccharide in human blood: pre-clinical evidence demonstrating the anti-inflammatory potential of biliverdin","volume":"5","author":"Bisht","year":"2014","journal-title":"J.\u00a0Clin. Cell. Immunol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.042_bib100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1253\/circj.CJ-08-1102","article-title":"Endothelial function and oxidative stress in cardiovascular diseases","volume":"73","author":"Higashi","year":"2009","journal-title":"Circ. J."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2014.12.042_bib101","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1096\/fj.04-2368fje","article-title":"Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats","volume":"19","author":"Lanone","year":"2005","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib102","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbrc.2009.06.029","article-title":"Bilirubin inhibits the TNFalpha-related induction of three endothelial adhesion molecules","volume":"386","author":"Mazzone","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.042_bib103","first-page":"151","article-title":"Bilirubin effect on endothelial adhesion molecules expression is mediated by the NF-kappaB signaling pathway","volume":"3","author":"Mazzone","year":"2009","journal-title":"Biosci. Trends"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.042_bib104","first-page":"387","article-title":"Decreased levels of advanced glycation end-products in patients with Gilbert syndrome","volume":"51","author":"Kalousova","year":"2005","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.atherosclerosis.2014.12.042_bib105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cca.2012.08.029","article-title":"Lower carotid intima media thickness is predicted by higher serum bilirubin in both non-diabetic and Type 2 diabetic subjects","volume":"414","author":"Dullaart","year":"2012","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.042_bib106","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0003319713507627","article-title":"Serum bilirubin level and aortic intima-media thickness in patients without clinical manifestation of atherosclerotic cardiovascular disease","volume":"65","author":"Kalkan","year":"2014","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib107","doi-asserted-by":"crossref","first-page":"e16165","DOI":"10.1371\/journal.pone.0016165","article-title":"Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by bilirubin at the blood-CSF and blood-brain barriers in the Gunn rat","volume":"6","author":"Gazzin","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2014.12.042_bib108","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1476-5381.2011.01413.x","article-title":"Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration","volume":"164","author":"Bulmer","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2014.12.042_bib109","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1016\/j.bmc.2008.02.008","article-title":"In\u00a0vitro permeability and metabolic stability of bile pigments and the effects of hydrophilic and lipophilic modification of biliverdin","volume":"16","author":"Bulmer","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"24","key":"10.1016\/j.atherosclerosis.2014.12.042_bib110","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.12.042_bib111","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J.\u00a0Clin. Investig."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.042_bib112","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/1523086041361587","article-title":"Oxidant stress and platelet activation in hypercholesterolemia","volume":"6","author":"Ferroni","year":"2004","journal-title":"Antioxid. Redox Signal."},{"issue":"Pt 5","key":"10.1016\/j.atherosclerosis.2014.12.042_bib113","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1042\/bst0311059","article-title":"Oxidant stress: a key determinant of atherothrombosis","volume":"31","author":"Loscalzo","year":"2003","journal-title":"Biochem. Soc. Trans."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.042_bib114","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/ATVBAHA.113.302919","article-title":"Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation","volume":"34","author":"Badrnya","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-0030-1251498","article-title":"Oxidized LDL-activated platelets induce vascular inflammation","volume":"36","author":"Daub","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2014.12.042_bib116","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.amjcard.2008.02.003","article-title":"Why have antioxidants failed in clinical trials?","volume":"101","author":"Steinhubl","year":"2008","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib117","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.thromres.2009.11.015","article-title":"Gamma tocopherol supplementation prevents exercise induced coagulation and platelet aggregation","volume":"125","author":"Vucinic","year":"2010","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.042_bib118","first-page":"422","article-title":"Effects of gamma-tocopherol supplementation on thrombotic risk factors","volume":"16","author":"Singh","year":"2007","journal-title":"Asia Pac. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.042_bib119","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/ajcn\/77.6.1466","article-title":"Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function","volume":"77","author":"Murphy","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.12.042_bib120","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.292.12.1433","article-title":"Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project","volume":"292","author":"Knoops","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib121","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0022-3476(69)80071-5","article-title":"The effect of bilirubin on the human platelet","volume":"74","author":"Suvansri","year":"1969","journal-title":"J.\u00a0Pediatr."},{"issue":"3 Suppl.\u00a0l","key":"10.1016\/j.atherosclerosis.2014.12.042_bib122","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1378\/chest.124.3_suppl.18S","article-title":"Thrombin and platelet activation","volume":"124","author":"Brass","year":"2003","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.042_bib123","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02859256","article-title":"Relationship between serum bilirubin and coagulation test results in 1-month-old infants","volume":"72","author":"Tiker","year":"2005","journal-title":"Indian J. Pediatr."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib124","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0049-3848(90)90146-4","article-title":"Bilirubin induces platelet aggregation","volume":"59","author":"Moiny","year":"1990","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1203\/00006450-197202000-00007","article-title":"Influence of bilirubin on human platelets","volume":"6","author":"Maurer","year":"1972","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib126","first-page":"423","article-title":"Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux","volume":"96","author":"Gerrard","year":"1979","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.042_bib127","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2460\/ajvr.70.4.472","article-title":"Effects of anticoagulant on pH, ionized calcium concentration, and agonist-induced platelet aggregation in canine platelet-rich plasma","volume":"70","author":"Callan","year":"2009","journal-title":"Am. J. Vet. Res."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2014.12.042_bib128","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0022-2275(20)41489-0","article-title":"Rapid association of unconjugated bilirubin with amorphous calcium phosphate","volume":"36","author":"van der Veere","year":"1995","journal-title":"J.\u00a0Lipid Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.042_bib129","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/01.ATV.0000118279.74056.8a","article-title":"Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in\u00a0vivo","volume":"24","author":"Lindenblatt","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/jcb.240450206","article-title":"GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium","volume":"45","author":"McEver","year":"1991","journal-title":"J.\u00a0Cell. Biochem."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2014.12.042_bib131","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jacc.2004.12.071","article-title":"Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates","volume":"45","author":"Yokoyama","year":"2005","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.042_bib132","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.CIR.103.4.491","article-title":"Soluble P-selectin and the risk of future cardiovascular events","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.12.042_bib133","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1538-7836.2009.03587.x","article-title":"P-selectin antagonism reduces thrombus formation in humans","volume":"7","author":"Chelliah","year":"2009","journal-title":"J.\u00a0Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib134","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e318142be0d","article-title":"Evidence for higher red blood cell mass in persons with unconjugated hyperbilirubinemia and Gilbert's syndrome","volume":"335","author":"Buyukasik","year":"2008","journal-title":"Am. J. Med. Sci."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.12.042_bib135","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/clinchem\/38.9.1853","article-title":"Sex- and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study","volume":"38","author":"Manolio","year":"1992","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib136","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MAJ.0b013e318223460f","article-title":"Bilirubin dependence on UGT1A1 polymorphisms, hemoglobin, fasting time and body mass index","volume":"343","author":"Rodrigues","year":"2012","journal-title":"Am. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.042_bib137","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MBC.0b013e32835e4230","article-title":"The effects of Gilbert's syndrome on the mean platelet volume and other hematological parameters","volume":"24","author":"Cure","year":"2013","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib138","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00001721-199603000-00011","article-title":"Platelet size: measurement, physiology and vascular disease","volume":"7","author":"Bath","year":"1996","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.042_bib139","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.it.2007.02.006","article-title":"Complement and coagulation: strangers or partners in crime?","volume":"28","author":"Markiewski","year":"2007","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0038-1642655","article-title":"Plasminogen activator inhibitor 1 (PAI-1) in plasma: its role in thrombotic disease","volume":"74","author":"Wiman","year":"1995","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.042_bib141","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrc.2014.04.150","article-title":"Biliverdin modulates the expression of C5aR in response to endotoxin in part via mTOR signaling","volume":"449","author":"Bisht","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib142","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0304-4165(93)90013-X","article-title":"A\u00a0beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin","volume":"1158","author":"Nakagami","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib143","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1055\/s-0038-1648857","article-title":"Platelet activation induced by interleukin-6: evidence for a mechanism involving arachidonic acid metabolism","volume":"72","author":"Oleksowicz","year":"1994","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.042_bib144","doi-asserted-by":"crossref","first-page":"H730","DOI":"10.1152\/ajpheart.00067.2011","article-title":"Endothelial C-reactive protein increases platelet adhesion under flow conditions","volume":"301","author":"Grad","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib145","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/blood.V82.2.513.513","article-title":"C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor","volume":"82","author":"Cermak","year":"1993","journal-title":"Blood"},{"issue":"1 Pt 2","key":"10.1016\/j.atherosclerosis.2014.12.042_bib146","first-page":"H107","article-title":"NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium","volume":"270","author":"Motterlini","year":"1996","journal-title":"Am. J. Physiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.042_bib147","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0014-5793(93)80353-V","article-title":"Bilirubin attenuates radical-mediated damage to serum albumin","volume":"331","author":"Neuzil","year":"1993","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.042_bib148","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0735-1097(02)02972-8","article-title":"Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with Type II diabetes mellitus","volume":"41","author":"Gresele","year":"2003","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.042_bib149","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1182\/blood-2013-04-491688","article-title":"Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways","volume":"122","author":"Wraith","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2014.12.042_bib150","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1161\/01.ATV.15.8.1131","article-title":"Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2","volume":"15","author":"Weidtmann","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014016645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014016645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T08:22:12Z","timestamp":1650874932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014016645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0021915014016645"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.042","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bilirubin, platelet activation and heart disease: A missing link to cardiovascular protection in Gilbert's syndrome?","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}